Cyclin D1 expression in KRAS mutant non-small cell lung cancer-old wine into new skins

被引：6

作者：

Goh, Kah Yee ^{[1
]}

Lim, Wan-Teck ^{[1
,2
,3
]}

机构：

[1] Natl Canc Ctr Singapore, Div Med Oncol, 11 Hosp Dr, Singapore, Singapore

[2] Duke NUS Med Sch, Off Acad & Clin Dev, Singapore, Singapore

[3] ASTAR, Inst Mol & Cell Biol, Proteos, Singapore

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2020年 / 9卷 / 06期

基金：

英国医学研究理事会;

关键词：

MUTATION; CARCINOMA;

D O I：

10.21037/tlcr-20-639

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2302 / 2304

页数：3

共 50 条

[41] The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line
Zuryn, Agnieszka
Litwiniec, Anna
Safiejko-Mroczka, Barbara
Klimaszewska-Wisniewska, Anna
Gagat, Maciej
Krajewski, Adrian
Gackowska, Lidia
Grzanka, Dariusz
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (06) : 2521 - 2533
[42] Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression
Ju, Z-S
Sun, B.
Bao, D.
Zhang, X-F
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) : 9465 - 9472
[43] Expression of cyclin B1, D1 and K in non-small cell lung cancer H1299 cells following treatment with sulforaphane
Zuryn, Agnieszka
Krajewski, Adrian
Klimaszewska-Wisniewska, Anna
Grzanka, Alina
Grzanka, Dariusz
ONCOLOGY REPORTS, 2019, 41 (02) : 1313 - 1323
[44] Cyclin D1 overexpression is an indicator of poor prognosis in resectable non small cell lung cancer
Keum, JS
Kong, G
Yang, SC
Shin, DH
Park, SS
Lee, JH
Lee, JD
BRITISH JOURNAL OF CANCER, 1999, 81 (01) : 127 - 132
[45] TWIST1 is a critical mediator of KRAS mutant tumorigenesis in human non-small cell lung cancer
Burns, Timothy F.
Dobromilskaya, Irina
Murphy, Sara C.
Gajula, Rajendra P.
Aziz, Khaled
Cho, Yoon-Jae
Tran, Phuoc T.
Rudin, Charles M.
CANCER RESEARCH, 2012, 72
[46] Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer
Gaurab Chakrabarti
Radiation Oncology, 10
[47] Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer
Chakrabarti, Gaurab
RADIATION ONCOLOGY, 2015, 10
[48] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
Jacqueline V. Aredo
Sukhmani K. Padda
Current Treatment Options in Oncology, 2018, 19
[49] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
Giorgia Maroni
Mahmoud A. Bassal
Indira Krishnan
Chee Wai Fhu
Virginia Savova
Rapolas Zilionis
Valerie A. Maymi
Nicole Pandell
Eva Csizmadia
Junyan Zhang
Barbara Storti
Julio Castaño
Riccardo Panella
Jia Li
Corinne E. Gustafson
Sam Fox
Rachel D. Levy
Claire V. Meyerovitz
Peter J. Tramontozzi
Kimberly Vermilya
Assunta De Rienzo
Stefania Crucitta
Daniela S. Bassères
Marla Weetall
Art Branstrom
Alessandra Giorgetti
Raffaele Ciampi
Marzia Del Re
Romano Danesi
Ranieri Bizzarri
Henry Yang
Olivier Kocher
Allon M. Klein
Robert S. Welner
Raphael Bueno
Maria Cristina Magli
John G. Clohessy
Azhar Ali
Daniel G. Tenen
Elena Levantini
Communications Biology, 4
[50] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
Maroni, Giorgia
Bassal, Mahmoud A.
Krishnan, Indira
Fhu, Chee Wai
Savova, Virginia
Zilionis, Rapolas
Maymi, Valerie A.
Pandell, Nicole
Csizmadia, Eva
Zhang, Junyan
Storti, Barbara
Castano, Julio
Panella, Riccardo
Li, Jia
Gustafson, Corinne E.
Fox, Sam
Levy, Rachel D.
Meyerovitz, Claire, V
Tramontozzi, Peter J.
Vermilya, Kimberly
De Rienzo, Assunta
Crucitta, Stefania
Basseres, Daniela S.
Weetall, Marla
Branstrom, Art
Giorgetti, Alessandra
Ciampi, Raffaele
Del Re, Marzia
Danesi, Romano
Bizzarri, Ranieri
Yang, Henry
Kocher, Olivier
Klein, Allon M.
Welner, Robert S.
Bueno, Raphael
Magli, Maria Cristina
Clohessy, John G.
Ali, Azhar
Tenen, Daniel G.
Levantini, Elena
COMMUNICATIONS BIOLOGY, 2021, 4 (01)

← 1 2 3 4 5 →